Atlas Trials

A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806

Clinical trial NCT01801293 · COMPLETED

Trial details

NCT number
NCT01801293
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
RSV Infection
Start date
2013-03-01
Primary completion
2013-04-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.